Dietary Tomato Powder Inhibits High-Fat Diet-Promoted Hepatocellular Carcinoma with Alteration of Gut Microbiota in Mice Lacking Carotenoid Cleavage Enzymes

Cancer Prev Res (Phila). 2018 Dec;11(12):797-810. doi: 10.1158/1940-6207.CAPR-18-0188. Epub 2018 Nov 16.

Abstract

Both incidence and death rate due to liver cancer have increased in the United States. Higher consumption of lycopene-rich tomato and tomato products is associated with a decreased risk of cancers. β-Carotene-15, 15'-oxygenase (BCO1), and β-carotene-9', 10'-oxygenase (BCO2) cleave lycopene to produce bioactive apo-lycopenoids. Although BCO1/BCO2 polymorphisms affect human and animal lycopene levels, whether dietary tomato consumption can inhibit high-fat diet (HFD)-promoted hepatocellular carcinoma (HCC) development and affect gut microbiota in the absence of BCO1/BCO2 is unclear. BCO1/BCO2 double knockout mice were initiated with a hepatic carcinogen (diethylnitrosamine) at 2 weeks of age. At 6 weeks of age, the mice were randomly assigned to an HFD (60% of energy as fat) with or without tomato powder (TP) feeding for 24 weeks. Results showed that TP feeding significantly decreased HCC development (67%, 83%, and 95% reduction in incidence, multiplicity, and tumor volume, respectively, P < 0.05). Protective effects of TP feeding were associated with (1) decreased hepatic inflammatory foci development and mRNA expression of proinflammatory biomarkers (IL1β, IL6, IL12α, monocyte chemoattractant protein-1, and inducible NO synthase); (2) increased mRNA expression of deacetylase sirtuin 1 and nicotinamide phosphoribosyltransferase involving NAD+ production; and (3) increased hepatic circadian clock genes (circadian locomotor output cycles kaput, period 2, and cryptochrome-2, Wee1). Furthermore, TP feeding increased gut microbial richness and diversity, and significantly decreased the relative abundance of the genus Clostridium and Mucispirillum, respectively. The present study demonstrates that dietary tomato feeding independent of carotenoid cleavage enzymes prevents HFD-induced inflammation with potential modulating gut microbiota and inhibits HFD-promoted HCC development.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular / etiology
  • Carcinoma, Hepatocellular / prevention & control*
  • Carotenoids / metabolism
  • Diet, High-Fat / adverse effects
  • Dietary Supplements*
  • Diethylnitrosamine / administration & dosage
  • Diethylnitrosamine / toxicity
  • Dioxygenases / genetics
  • Dioxygenases / metabolism
  • Gastrointestinal Microbiome / physiology
  • Humans
  • Liver Neoplasms / etiology
  • Liver Neoplasms / prevention & control*
  • Liver Neoplasms, Experimental / etiology
  • Liver Neoplasms, Experimental / prevention & control*
  • Male
  • Mice
  • Mice, Knockout
  • Plant Extracts / administration & dosage*
  • Powders
  • Solanum lycopersicum / chemistry*
  • beta-Carotene 15,15'-Monooxygenase / genetics
  • beta-Carotene 15,15'-Monooxygenase / metabolism

Substances

  • Plant Extracts
  • Powders
  • Carotenoids
  • Diethylnitrosamine
  • Dioxygenases
  • Bco1 protein, mouse
  • Bco2 protein, mouse
  • beta-Carotene 15,15'-Monooxygenase